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Abstract
Purpose Primary ciliary dyskinesia (PCD) is characterised by repeated upper and lower respiratory tract infections, neutro-
philic airway inflammation and obstructive airway disease. Different ultrastructural ciliary defects may affect lung function 
decline to different degrees. Lung clearance index (LCI) is a marker of ventilation inhomogeneity that is raised in some but 
not all patients with PCD. We hypothesised that PCD patients with microtubular defects would have worse (higher) LCI 
than other PCD patients.
Methods Spirometry and LCI were measured in 69 stable patients with PCD. Age at testing, age at diagnosis, ethnicity, 
ciliary ultrastructure, genetic screening result and any growth of Pseudomonas aeruginosa was recorded.
Results Lung clearance index was more abnormal in PCD patients with microtubular defects (median 10.24) than those with 
dynein arm defects (median 8.3, p = 0.004) or normal ultrastructure (median 7.63, p = 0.0004). Age is correlated with LCI, 
with older patients having worse LCI values (p = 0.03, r = 0.3).
Conclusion This study shows that cilia microtubular defects are associated with worse LCI in PCD than dynein arm defects 
or normal ultrastructure. The patient’s age at testing is also associated with a higher LCI. Patients at greater risk of obstruc-
tive lung disease should be considered for more aggressive management. Differences between patient groups may potentially 
open avenues for novel treatments.
Keywords Lung function · Paediatrics · Rare disease · Ciliopathy
Introduction
Primary ciliary dyskinesia (PCD) is an inherited condition 
characterised by repeated upper and lower respiratory tract 
infections and chronic secretory otitis media. Approximately 
50% patients have disorders of laterality. Morbidity is signif-
icant with most patients developing obstructive lung disease 
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and bronchiectasis [1–4]. Diagnosis is complex, and may 
include combinations of suggestive clinical features, low 
nasal nitric oxide and abnormal ciliary waveform on high-
speed videomicroscopy, abnormal ultrastructure defect on 
electron microscopy (EM) and/or positive genetic tests [5]. 
There is no uniformly applicable gold standard. Normal cili-
ary ultrastructure and common PCD ultrastructural defects 
are shown in Fig. 1.
Ciliary ultrastructural abnormalities can be divided 
into three broad classes; defects affecting the dynein arms, 
defects of the microtubules and PCD with normal ultras-
tructure. The majority of defects occur in the dynein motor 
proteins which drive ciliary beating, known as the inner and 
outer dynein arms (IDA, ODA, respectively); these may be 
caused by gene mutations either leading to failure of syn-
thesis of proteins which form the structural components of 
the dynein arm proteins or proteins involved in their assem-
bly [1]. Defects of the microtubular arrangement include 
absence of the central microtubular pair together with trans-
position of a peripheral doublet (usually caused by defects in 
radial spoke head genes); and microtubular disorganisation, 
also often with loss of the inner dynein arm, which usually 
results from mutations in the ‘molecular ruler’ and dynein 
regulatory complex proteins [6, 7]. 15–30% of patients with 
PCD will have no demonstrable ultrastructural defect on 
TEM, including those carrying mutations in genes encoding 
specific ODA (DNAH11) and central pair (HYDIN) proteins 
[8]. In these patients, confirmation of the diagnosis is made 
by identification of biallelic mutations in a PCD disease-
causing gene or deemed ‘highly likely’ based on persistent 
diagnostic ciliary waveform abnormalities on high-speed 
videomicroscopy which may be combined with suggestive 
clinical features and low nasal nitric oxide [9].
Primary ciliary dyskinesia is a heterogeneous condi-
tion, with wide variability in clinical status, lung function 
and outcomes. Previous studies using spirometry, the main 
tool for accessing disease severity in terms of lung func-
tion [specifically forced expiratory volume in 1 s  (FEV1)], 
have been conflicting [10–12]. A large study recently found 
spirometry is worse in patients with microtubular defects 
than in patients with ODA ± IDA defects, although not all 
investigators have reported this [13–17].
Lung clearance index (LCI) is derived from multi-breath 
washout of nitrogen or an exogenous inert gas and is a sen-
sitive measure of distal airway function [18]. The normal 
range is broadly similar from school age to adulthood. LCI 
has been shown to be more sensitive to early airways disease 
than spirometry in cystic fibrosis [19], and is abnormal in 
patients with PCD [17, 20]. It may be that this more sensitive 
parameter is a better tool to access lung function differences 
in PCD than spirometry.
We hypothesised that LCI would vary between PCD 
patients with different ultrastructural defects, with the worst 
results in those with microtubular defects.
Materials and Methods
Ethics
The clinical study was approved by NRES Committee 
South East Coast—Brighton & Sussex (REC reference: 10/
H1101/69). Genetic analysis was approved by NRES Com-
mittee London Bloomsbury for UCL Great Ormond Street 
Institute of Child Health/Great Ormond Street Hospital 
(REC reference: 08/H0713/82).
Recruitment
PCD patients with normal ultrastructure, microtubular 
defects or outer dynein arm with or without inner dynein 
arm (ODA ± IDA) were recruited.
Initial recruitment was conducted across the paediat-
ric and adult age range, and 74 paediatric and adult PCD 
patients willing to take part were recruited from the res-
piratory clinics at the Royal Brompton Hospital. However, 
five patients over 50 years of age originally recruited have 
been excluded from the main dataset. These patients were 
Fig. 1  A diagram of a normal 
cilium on the left, with a normal 
ultrastructure, showing micro-
tubular doublets, a central pair, 
nexin links and radial spokes 
and inner and outer dynein 
arms. The electron micrographs 
on the right show common 
PCD defects, in A, absence of 
the outer dynein arms, in B, 
absence of inner dynein arms, in 
C, absence of inner dynein arms 
and microtubular disorganisa-
tion and in D, absence of both 
the inner and outer dynein arms
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all of white ethnicity, 4/5 had an ODA ± IDA defect (1 had 
microtubular defect) and we were unable to recruit equiva-
lent patients of other ethnic origin, or with defects other than 
ODA ± IDA, in this age group. For this reason, they were 
removed from the main analysis due to introducing an unac-
ceptable risk of bias into the data. Demographics of these 
removed patients are available in the OLS.
The remaining 69 patients are shown in Table 1. All had 
undergone detailed evaluation including history and clinical 
examination including a nasal ciliary brush biopsy which 
was sent for light microscopic examination and ultrastruc-
tural examination by EM.
Inclusion criteria were a positive or highly likely diag-
nosis of PCD according to current European guidelines [9] 
based on:
1. A hallmark TEM defect.
2. Biallelic changes in a known PCD gene.
3. Consistent reproducible defects on high-speed video 
microscopy, coupled with persistently low nasal NO and 
clinical features of PCD.
The date on which the EM sample was received was used 
as a surrogate for age at diagnosis (full details of diagnostic 
process are given below). Patients were stable at time of 
recruitment with no increase in symptoms in the 2 weeks 
prior to testing, and no new pathogens grown on cough swab 
or sputum sample. Note was made if the patient had ever 
grown Pseudomonas aeruginosa. As PCD is a rare disease, 
all eligible patients were approached and no statistical sam-
pling method was used.
Lung Function
Patients performed spirometry (ATS/ERS guidelines [21]), 
from which forced expiratory volume in 1 s  (FEV1) and 
forced expiratory flow 25–75% of vital capacity  (FEF25–75%) 
z-scores were calculated using the global lungs initiative 
(GLI) [22]. At the same visit, after spirometry, they per-
formed multiple breath washout test (MBW) from which 
LCI was calculated. A sulphur hexafluoride  (SF6) washout 
with a photoacoustic gas analyser (Innocor, Innovision, Den-
mark) was used, with an open breathing circuit, as described 
previously, with a minimum of 2 runs of acceptable quality, 
in accordance with ERS/ATS guidelines [18, 20, 23]. Abnor-
mal LCI was defined as > 7.4 [18, 20].
Electron Microscopy
Samples were fixed in 2.5% glutaraldehyde in cacodylate 
buffer, processed for electron microscopy (EM) and defects 
were quantified [7]. Briefly, cells were washed in sodium 
cacodylate buffer, post-fixed with 1% osmium tetroxide and 
centrifuged in 2% agar to generate a pellet. Using a series 
of increasing concentrations of methanol followed by pro-
pylene oxide, cells were dehydrated before being embed-
ded in resin. 70–90 nm sections were cut using a Reichert 
Ultracut-E ultramicrotome and mounted onto copper grids. 
Heavy metal staining used uranyl acetate and lead citrate. 
Assessment of the respiratory epithelium and ciliary ultras-
tructure were made on a transmission electron microscope. 
Quantification of cells, microtubular arrangement in the 
axoneme and presence of dynein arms was performed by a 
clinical electron microscopist. 100–300 cilia were analysed 
in transverse section and note of ciliary orientation and cell 
health and appearance of longitudinal ciliary sections was 
made before a diagnosis of PCD confirmed. Care was taken 
to assess cilia from a number of healthy cells from locations 
proximal and distal to the epithelial cell surface.
Genetics
Mutation data were generated using next-generation 
sequencing methods, either whole exome sequencing or 
screening of custom targeted gene panels employing TruSeq 
(Illumina Inc) and SureSelect (Agilent Technologies) sys-
tems and an illumina sequencing system with variant calling 
performed as previously described [24, 25].
Statistical Methods
Sample size was opportunistic, since there are no data to 
inform a power calculation. Non-parametric statistics were 
used for lung function results. Differences between three 
and more groups were assessed by Kruskal–Wallis test; and 
then pairwise between two groups by Mann–Whitney test. 
Spearman’s r was used for correlation.
SPSS (IBM, NY, USA) was used for statistical analysis; 
graphs were plotted using GraphPad Prism (GraphPad Soft-
ware Inc, CA, USA).
Results
Ciliary Ultrastructure
Demographics are given in Table 1. There was no significant 
difference between the three groups in age at testing, age at 
diagnosis, BMI or nasal nitric oxide. Median LCI,  FEV1 and 
 FEF25–75% were abnormal in all three groups (Fig. 2). The 
microtubular defects group all had abnormal LCI, but not 
 FEV1 or  FEF25–75%. Genotyping was available for 55 out of 
the 69 PCD patients (Table 2).
On non-parametric statistical analysis, LCI was signifi-
cantly worse in patients with microtubular defects than 
the other two groups (Table 1; Fig. 2, Kruskal–Wallis 
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result for three groups p = 0.0013, pairwise Mann–Whit-
ney result for microtubular defects versus ODA ± IDA 
p = 0.004, and microtubular defects vs normal ultrastruc-
ture p = 0.0004).  FEV1 and  FEF25–75% were also signifi-
cantly worse in patients with microtubular defects com-
pared with the group with normal ultrastructure (Table 1; 
Fig. 2, Kruskal–Wallis result for three groups p = 0.04 
for  FEV1 z-score and p = 0.03 for  FEF25–75%, pairwise 
Mann–Whitney result for normal ultrastructure versus 
microtubular defects p = 0.02 for both, no other signifi-
cant differences).
Current Age and Age at Diagnosis
Current age (at time of testing) was correlated with LCI and 
 FEV1 (Fig. 3; age and LCI p = 0.04 r = 0.3, age and  FEV1 
p = 0.008, r = − 0.3), but not  FEF25–75%. LCI was not sig-
nificantly correlated with age at diagnosis, whereas  FEV1 
Fig. 2  Differences in lung function tests between groups. Those with normal ultrastructure had the best results, and those with microtubular 
defects the worst, with ODA ± IDA intermediate. Panel A  FEV1 *p = 0.02; Panel B  FEF25–75% *p = 0.02; Panel C LCI *p = 0.04 **p = 0.0004
Table 2  Ultrastructure defect groupings, including genetic results where available
*Three patients with no sample taken for genetics or no gene found showed consistent reproducible abnormalities on high-speed video micros-
copy
Group Number Genetic result
ODA ± IDA ODA 39 9 DNAH5, 1 ARMC4, 1 LRRC6, 1 DNAAF3, 2 DNAI1, 1 pathogenic mutations in 
a known PCD gene were not found, 9 no sample taken24
ODA + IDA 15 5 DNAAF3, 1 DYX1C1, 1 ZMYND10, 1 CCDC103, 4 LRRC6,, 1 SPAG1, 2 no 
sample taken
Normal ultrastructure 14 6 DNAH11, 3 HYDIN, 1 CCDC103, 1 RPGR
1 no sample taken, 2 pathogenic mutations in a known PCD gene were not found*
Microtubular defects Central complex 16 2 RSPH4A, 2 no sample taken
4
Microtubular defects + IDA 12 5 CCDC39, 4 CCDC40, 1 pathogenic mutations in a known PCD gene were not 
found, 2 no sample taken
Fig. 3  Relationship between age 
(a) and age at diagnosis (b) and 
LCI. Age and LCI correlate sig-
nificantly (p = 0.0012, r = 0.4), 
as does age and  FEV1 z-score 
(p = 0.004, r = 0.3)
236 Lung (2018) 196:231–238
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was inversely correlated (p = 0.02, r = − 0.4). It was possible 
that younger patients were diagnosed earlier, as awareness 
of PCD has improved, thus introducing a bias, but there was 
no change in age at diagnosis over time (results in OLS).
Ethnicity
Ethnic groups were equally distributed between EM groups 
(Table 1) and there is no statistically significant difference 
between LCI,  FEV1,  FEF25–75%, nasal nitric oxide, age or age 
at diagnosis between them.
Ciliary Function
45 patients had predominantly static cilia on light micros-
copy, and 21 had predominantly dyskinetic. There was no 
difference in LCI,  FEV1 and  FEF25–75% between these groups 
(data in OLS). Where beat frequency was measurable with 
non-static cilia, there was no relationship between beat fre-
quency and lung function (see OLS for full data). There was 
no relationship between nasal nitric oxide results and lung 
function (see OLS).
Discussion
We have shown that PCD patients with microtubular defects 
have worse LCI compared to groups with normal ultrastruc-
ture and dynein arm defects. Microtubular defects were first 
linked to comparatively worse lung function and decline in 
previous spirometry-based studies [13, 16], but these dif-
ferences in LCI are novel, showing the utility of this test 
as a sensitive tool to investigate lung function differences 
in PCD. This study supports the hypothesis that there are 
potential outcome differences between different ultrastruc-
tural groups.
Unlike in previous work, there was no significant dif-
ference in  FEV1 and  FEF25–75% between ODA ± IDA and 
microtubular defects [13]. This may be because the previ-
ous article used percent predicted, whereas we have used 
z-scores. Furthermore, the Wilcoxon signed-rank test for 
comparison between groups was used, whilst here we used 
a more stringent approach [16]. However, more data are 
needed to understand this discrepancy.
The mechanism by which different ultrastructural defects 
may give rise to differences in lung function in vivo is not 
clear. Ciliary motility differs between defects which may 
affect mucociliary transport, but why microtubular defect 
patients with some ciliary motility (such as the circling 
pattern seen in transposition defects) should have worse 
lung function than ODA ± IDA patients with completely 
static cilia is not known. Cilia also have a role in cell sig-
nalling, and we speculate that this could differ in different 
ultrastructural groups. In our centre, treatment decisions 
are based on clinical assessment rather than ultrastructure 
defect, so it is unlikely any differences arise from treatment 
differences.
One weakness of this study is the small cohort size. Until 
very recently, there was no commercially available validated 
LCI equipment, and measurements were restricted to tertiary 
centres, and so very large multicentre cohort studies (such 
as those published in spirometry) were not possible. Recent 
advances in equipment mean this will change in the com-
ing years, and so establishing the role of this test in these 
patients is important.
Green et al. [26] found no significant correlation between 
age or age at diagnosis and lung function in their 2012 PCD 
cohort. In our cohort we found a correlation between age 
and LCI and FEV1. This could have been due to a number 
of factors. Our cohort is larger so may have been better pow-
ered to detect this difference, and also Green et al’s cohort 
contained no patients over the age of 18 years, so the effect 
may be less pronounced in paediatric patients. In this study, 
we have used age at EM diagnosis as a surrogate measure for 
age at diagnosis, due to incomplete and varied history of our 
patients prior to their referral to the PCD centre. This is an 
acknowledged compromise and may be why no significant 
association was found.
As many patients do not solely attend our clinic, the 
microbiological results are incomplete. However, the preva-
lence of Pseudomonas aeruginosa seen here (30%) is similar 
to previous reports; a large multicentre study gives a preva-
lence of 37% overall [11], a large adult patient cohort 45% 
[16] and another showed a varying prevalence in different 
calendar years of between 15 and 47% [27].
In our study, median BMI for all ultrastructure groups 
was in the healthy range (Table 1). This differs from the 
previous study [13], where microtubular defects patients 
had a lower BMI than the other groups. The exact reason 
for this discrepancy is unclear and may relate to differences 
in management protocols between centres, but excludes the 
possibility that low BMI was the cause of poorer lung func-
tion results in our microtubular defects patients.
In summary, in PCD, microtubular defects ultrastruc-
ture group and older age are associated with worse LCI. 
We cannot explain this intriguing finding, and more work is 
needed to address the pathways whereby different ultrastruc-
ture affects patient outcomes. In the future, determining the 
reasons for these differences could open up new treatment 
pathways, and delineation of high risk groups may allow 
more targeted intensive treatment to improve prognosis.
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